Results from secondary analysis suggest future work is needed to extend the prevention intervention to address additional chronic conditions and substance use.
Three key drivers of the perennial increase in OA prevalence are population growth, aging, and obesity, said authors of the analysis for the Global Burden of Disease study.
Investigators report a 30% reduced risk of total joint replacement in persons with type 2 diabetes treated with metformin vs those who did not receive the drug.